Polaryx Therapeutics, Inc. Common Stock (PLYX) Live Share Price, Invest From India

Polaryx Therapeutics, Inc. Common Stock Stock Performance

as on May 13, 2026 at 6:58 am IST

Day's Low
Day's High
$3.00
Day's Price Range
$3.46
$3.29
8.81%
Downside
5.17%
Upside
52 Week's Low
52 Week's High
52-Week Price Range
$3.29
100.00%
Downside
-100.00%
Upside

Polaryx Therapeutics, Inc. Common Stock share price movements today

Previous Close: $3.39
Open: $3.39
Volume: 667.0K
Day's Low - High: $3.00 - $3.46

Polaryx Therapeutics, Inc. Common Stock Historical Returns

1 Month Return: -40.32 %
3 Month Return: + 16.1 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Polaryx Therapeutics, Inc. Common Stock Stock Fundamentals & Key Indicators

Check Polaryx Therapeutics, Inc. Common Stock market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$173.3M

EPS (TTM)

-0.12

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-193.71%

Polaryx Therapeutics, Inc. Common Stock vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Polaryx Therapeutics, Inc. Common Stock with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Polaryx Therapeutics, Inc. Common Stock	NA	$173.3M	NA	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$39.4B	113.59%	74.13	12.55%
BeiGene, Ltd.	NA	$32.2B	NA	70.46	8.94%
Vertex Pharmaceuticals Inc	BUY	$109.1B	104.61%	25.51	35.51%
Regeneron Pharmaceuticals Inc	BUY	$74.9B	40.55%	17.45	29.65%

Indian Investors' Interest in Polaryx Therapeutics, Inc. Common Stock Stock

Search interest for Polaryx Therapeutics, Inc. Common Stock Stock has decreased by -62% in the last 30 days, reflecting a downward trend in search activity.

Time period: April 13, 2026 to May 13, 2026

Change:-62% versus previous 30 day period

Polaryx Therapeutics, Inc. Common Stock Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-
Operating Income	0	0	-5	0	0	0
EBITDA	0	0	-5	0	0	0
Interest Expense	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-
Income Before Tax	0	0	-5	-1	-1	-1
Income Tax Expense	-	-	-	-	-	-
Net Income	0	0	-5	-1	-1	-1
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Polaryx Therapeutics, Inc. Common Stock Annual Profit & Loss

All numbers in Millions USD

	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-
Gross Profit	-	-	-
Operating Income	-3	-4	-7
EBITDA	-3	-4	-7
Interest Expense	-	-	-
Depreciation	-	-	-
Income Before Tax	-3	-30	-8
Income Tax Expense	-	-	-
Net Income	-3	-30	-8
Net Profit Margin	0.00%	0.00%	0.00%

Polaryx Therapeutics, Inc. Common Stock Quarterly Cash Flow

All numbers in Millions USD

	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	0	-5	-1	-1	-1
Operating Cash Flow	0	0	0	0	-1
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	2	0	-	3	0
Change in Cash	1	0	0	2	0

Polaryx Therapeutics, Inc. Common Stock Annual Cash Flow

All numbers in Millions USD

	Dec 2024	Dec 2025
Net Income	-30	-8
Operating Cash Flow	-2	-3
Investing Cash Flow	-	-
Financing Cash Flow	7	4
Change in Cash	4	0

Insights on Polaryx Therapeutics, Inc. Common Stock

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NEGATIVE IMPACT
Price Dip
In the last 7 days, PLYX stock has moved down by -10.8%

About Polaryx Therapeutics, Inc. Common Stock

Polaryx Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of disease-modifying therapies for rare and pediatric lysosomal storage disorders in the United States. Its pipeline includes PLX-100, a preclinical stage orally administrable combination therapy; PLX-200, a repurposed oral small molecule for the treatment of LSDs; PLX-300, a preclinical stage orally administrable combination therapy; and PLX-400, a preclinical stage novel gene therapy candidate. The company was founded in 2014 and is based in Paramus, New Jersey.

Organisation	Polaryx Therapeutics, Inc. Common Stock
Headquarters	South Tower, Paramus, NJ, United States, 07652
Industry	Biotechnology
CEO	Mr. Alex Yang J.D., L.L.M.
E-voting on shares	Click here to vote

Key Management of Polaryx Therapeutics, Inc. Common Stock

Name	Title
Mr. Andrew John O	Chief Investment Officer
Dr. Lisa L. Bollinger M.D.	Chief Medical Officer
Dr. Shrijay Vijayan M.B.A., Ph.D.	Chief Scientific & Business Development Officer
Mr. Wuxin Zhu P.M.P., Ph.D.	Chief Chemistry, Manufacturing & Controls Officer
Mr. Alex Yang J.D., L.L.M.	CEO & Chair of Board
Mr. G. Michael Landis CPA	CFO & Director

FAQs

What is Polaryx Therapeutics, Inc. Common Stock share price today?

Polaryx Therapeutics, Inc. Common Stock share price today is $3.29 as on May 13, 2026 at 1:28 am IST at the close of the market. Polaryx Therapeutics, Inc. Common Stock share today touched a day high of $3.46 and a low of $3.

What is the 52 week high and 52 week low for Polaryx Therapeutics, Inc. Common Stock share?

Polaryx Therapeutics, Inc. Common Stock share touched a 52 week high of $ on January 1, 1970 and a 52 week low of $ on January 1, 1970. Polaryx Therapeutics, Inc. Common Stock stock price today i.e. May 13, 2026 at 1:28 am IST is closed at $3.29,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Polaryx Therapeutics, Inc. Common Stock's market capitalisation today?

Polaryx Therapeutics, Inc. Common Stock market capitalisation is $0.00T as on May 13, 2026 at 1:28 am IST.

How to invest in Polaryx Therapeutics, Inc. Common Stock Stock (PLYX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Polaryx Therapeutics, Inc. Common Stock on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Polaryx Therapeutics, Inc. Common Stock Shares that will get you 0.4559 shares as per Polaryx Therapeutics, Inc. Common Stock share price of $3.29 per share as on May 13, 2026 at 1:28 am IST.

What is the minimum amount required to buy Polaryx Therapeutics, Inc. Common Stock Stock (PLYX) from India?

Indian investors can start investing in Polaryx Therapeutics, Inc. Common Stock (PLYX) shares with as little as ₹95.618 or $1 (as of May 13, 2026 at 6:37 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹956.18 in Polaryx Therapeutics, Inc. Common Stock stock (as per the Rupee-Dollar exchange rate as on May 13, 2026 at 6:37 am IST). Based on Polaryx Therapeutics, Inc. Common Stock share’s latest price of $3.29 as on May 13, 2026 at 1:28 am IST, you will get 3.0395 shares of Polaryx Therapeutics, Inc. Common Stock. Learn more about fractional shares .